Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

Morten L Hansen; Rikke Sørensen; Mette T Clausen; Marie Louise Fog-Petersen; Jakob Raunsø; Niels Gadsbøll; Gunnar H Gislason; Fredrik Folke; Søren Andersen; Tina K Schramm; Steen Z Abildstrøm; Henrik E Poulsen; Lars Køber; Christian Torp-Pedersen

doi:http://dx.doi.org/10.1001/archinternmed.2010.271

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

Morten L Hansen, Rikke Sørensen, Mette T Clausen, Marie Louise Fog-Petersen, Jakob Raunsø, Niels Gadsbøll, Gunnar H Gislason, Fredrik Folke, Søren Andersen, Tina K Schramm, Steen Z Abildstrøm, Henrik E Poulsen, Lars Køber, Christian Torp-Pedersen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

788 Citationer (Scopus)

Abstract

Patients with atrial fibrillation (AF) often require anticoagulation and platelet inhibition, but data are limited on the bleeding risk of combination therapy.

Originalsprog	Engelsk
Tidsskrift	Archives of Internal Medicine
Vol/bind	170
Udgave nummer	16
Sider (fra-til)	1433-41
Antal sider	9
ISSN	0003-9926
DOI	https://doi.org/10.1001/archinternmed.2010.271
Status	Udgivet - 13 sep. 2010

Adgang til dokumentet

http://dx.doi.org/10.1001/archinternmed.2010.271

Citationsformater

Hansen, M. L., Sørensen, R., Clausen, M. T., Fog-Petersen, M. L., Raunsø, J., Gadsbøll, N., Gislason, G. H., Folke, F., Andersen, S., Schramm, T. K., Abildstrøm, S. Z., Poulsen, H. E., Køber, L., & Torp-Pedersen, C. (2010). Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Archives of Internal Medicine, 170(16), 1433-41. https://doi.org/10.1001/archinternmed.2010.271

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. / Hansen, Morten L; Sørensen, Rikke; Clausen, Mette T; Fog-Petersen, Marie Louise; Raunsø, Jakob; Gadsbøll, Niels; Gislason, Gunnar H ; Folke, Fredrik; Andersen, Søren; Schramm, Tina K; Abildstrøm, Steen Z; Poulsen, Henrik E ; Køber, Lars ; Torp-Pedersen, Christian.

I: Archives of Internal Medicine, Bind 170, Nr. 16, 13.09.2010, s. 1433-41.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Hansen, ML, Sørensen, R, Clausen, MT, Fog-Petersen, ML, Raunsø, J, Gadsbøll, N, Gislason, GH , Folke, F, Andersen, S, Schramm, TK, Abildstrøm, SZ, Poulsen, HE , Køber, L & Torp-Pedersen, C 2010, 'Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation', Archives of Internal Medicine, bind 170, nr. 16, s. 1433-41. https://doi.org/10.1001/archinternmed.2010.271

Hansen, Morten L ; Sørensen, Rikke ; Clausen, Mette T ; Fog-Petersen, Marie Louise ; Raunsø, Jakob ; Gadsbøll, Niels ; Gislason, Gunnar H ; Folke, Fredrik ; Andersen, Søren ; Schramm, Tina K ; Abildstrøm, Steen Z ; Poulsen, Henrik E ; Køber, Lars ; Torp-Pedersen, Christian. / Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. I: Archives of Internal Medicine. 2010 ; Bind 170, Nr. 16. s. 1433-41.

@article{4b45c5d1859043f697d80be1562437cf,

title = "Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation",

abstract = "Patients with atrial fibrillation (AF) often require anticoagulation and platelet inhibition, but data are limited on the bleeding risk of combination therapy.",

author = "Hansen, {Morten L} and Rikke S{\o}rensen and Clausen, {Mette T} and Fog-Petersen, {Marie Louise} and Jakob Rauns{\o} and Niels Gadsb{\o}ll and Gislason, {Gunnar H} and Fredrik Folke and S{\o}ren Andersen and Schramm, {Tina K} and Abildstr{\o}m, {Steen Z} and Poulsen, {Henrik E} and Lars K{\o}ber and Christian Torp-Pedersen",

year = "2010",

month = sep,

day = "13",

doi = "http://dx.doi.org/10.1001/archinternmed.2010.271",

language = "English",

volume = "170",

pages = "1433--41",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "The JAMA Network",

number = "16",

}

TY - JOUR

T1 - Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

AU - Hansen, Morten L

AU - Sørensen, Rikke

AU - Clausen, Mette T

AU - Fog-Petersen, Marie Louise

AU - Raunsø, Jakob

AU - Gadsbøll, Niels

AU - Gislason, Gunnar H

AU - Folke, Fredrik

AU - Andersen, Søren

AU - Schramm, Tina K

AU - Abildstrøm, Steen Z

AU - Poulsen, Henrik E

AU - Køber, Lars

AU - Torp-Pedersen, Christian

PY - 2010/9/13

Y1 - 2010/9/13

N2 - Patients with atrial fibrillation (AF) often require anticoagulation and platelet inhibition, but data are limited on the bleeding risk of combination therapy.

AB - Patients with atrial fibrillation (AF) often require anticoagulation and platelet inhibition, but data are limited on the bleeding risk of combination therapy.

U2 - http://dx.doi.org/10.1001/archinternmed.2010.271

DO - http://dx.doi.org/10.1001/archinternmed.2010.271

M3 - Journal article

VL - 170

SP - 1433

EP - 1441

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 16

ER -